Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2017-04-24 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
股东大会工作条例（2017年4月修订）
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting Work Rules" of a company, detailing the procedures, powers, and regulations governing the company's shareholders' meetings. It includes chapters on the general principles, convening of meetings, proposals and notifications, meeting conduct, voting and resolutions, and supplementary provisions. The content is a governance document outlining internal rules and procedures related to shareholder meetings, rather than a report of financial results, announcements, or other filings. It does not contain financial statements, audit information, or voting results. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2017-04-24 Chinese
关于为子公司银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing guarantees for bank credit to its subsidiaries. It includes details about the guarantee amount, the subsidiaries involved, board and independent directors' opinions, and related approvals. The document is relatively short (2129 characters) and does not contain financial statements or detailed financial analysis. It is a formal announcement about a financing-related guarantee but not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company financing activities or capital structure changes such as guarantees for bank credit.
2017-04-24 Chinese
独立董事关于公司会计政策变更的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from the independent directors regarding a change in the company's accounting policies. It references regulatory guidelines and confirms the appropriateness of the accounting policy change without presenting financial statements or detailed financial data. The document is short (472 characters) and serves as an attestation or certification rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and not a full audit report or annual report.
2017-04-24 Chinese
经世律师事务所关于公司2017年度限制性股票股权激励计划之法律意见书
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding a 2017 restricted stock equity incentive plan for JinYu Biotechnology Co., Ltd. It extensively discusses the legal compliance, conditions, procedures, and disclosures related to the company's stock incentive plan. The content focuses on the legal and procedural aspects of a stock-based compensation plan, which is a form of capital/financing activity related to equity incentives. It is not an annual report, audit report, earnings release, or any other financial report. It is also not a simple announcement or a proxy solicitation. The document is a legal opinion on a capital/financing matter (equity incentive plan). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or certification, so it is not RNS or RPA.
2017-04-24 Chinese
独立董事关于公司会计政策变更的独立意见
Regulatory Filings Classification · 95% confidence The document is a statement from independent directors regarding a change in the company's accounting policy. It references regulatory guidelines and confirms the appropriateness of the accounting policy change without presenting financial data or a full report. The document length is very short (472 characters), and it is essentially an independent opinion or certification related to accounting policy changes. This fits best under Regulatory Filings (RNS) as it is a regulatory compliance-related statement rather than a full audit report or annual report.
2017-04-24 Chinese
关于召开2016年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2016 Annual General Meeting (AGM) of 金宇生物技术股份有限公司, including details such as the date, voting methods, agenda items, and instructions for shareholders. It contains no actual financial statements or detailed financial analysis but rather logistical and procedural information about the AGM. The document is approximately 4897 characters, which is relatively short and focused on the meeting notice and agenda rather than the full annual report or financial results. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself.
2017-04-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.